Binding of Fidarestat Stereoisomers with Aldose Reductase
Open Access
- 21 November 2006
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 7 (11) , 519-536
- https://doi.org/10.3390/i7110519
Abstract
The stereospecificity in binding to aldose reductase (ALR2) of two fidarestat {6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide} stereoisomers [(2S,4S)and (2R,4S)] has been investigated by means of molecular dynamics simulations using freeenergy integration techniques. The difference in the free energy of binding was found to be2.0 ± 1.7 kJ/mol in favour of the (2S,4S)-form, in agreement with the experimentalinhibition data. The relative mobilities of the fidarestats complexed with ALR2 indicate alarger entropic penalty for hydrophobic binding of (2R,4S)-fidarestat compared to (2S,4S)-fidarestat, partially explaining its lower binding affinity. The two stereoisomers differmainly in the orientation of the carbamoyl moiety with respect to the active site and rotationof the bond joining the carbamoyl substituent to the ring. The detailed structural andenergetic insights obtained from out simulations allow for a better understanding of thefactors determining stereospecific inhibitor-ALR2 binding in the EPF charges model.Keywords
This publication has 50 references indexed in Scilit:
- Aldose reductase structures: implications for mechanism and inhibitionCellular and Molecular Life Sciences, 2004
- Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a Potential Substrate for New Aldose Reductase InhibitorsJournal of Medicinal Chemistry, 1999
- 1-Benzopyran-4-one Antioxidants as Aldose Reductase InhibitorsJournal of Medicinal Chemistry, 1999
- Hyperglycemia and cardiovascular disease in type 2 diabetes.Diabetes, 1999
- Contributions of polyol pathway to oxidative stress in diabetic cataractThe FASEB Journal, 1999
- Highly Selective Aldose Reductase Inhibitors. 3. Structural Diversity of 3-(Arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic AcidsJournal of Medicinal Chemistry, 1997
- Synthesis, Activity, and Molecular Modeling of a New Series of Tricyclic Pyridazinones as Selective Aldose Reductase InhibitorsJournal of Medicinal Chemistry, 1996
- Aldose reductase inhibitors and their potential for the treatment of diabetic complicationsTrends in Pharmacological Sciences, 1994
- Biological activities and quantitative structure-activity relationships of spiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-triones as aldose reductase inhibitorsJournal of Medicinal Chemistry, 1992
- The role of aldose reductase in the development of diabetic complicationsMedicinal Research Reviews, 1988